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ABSTRACT 
This paper reports the fabrication of gelatin/karaya gum microspheres by emulsion crosslinking method for controlled release of distigmine 
bromide. The microspheres were crosslinked with the help of glutaraldehyde and used for controlled oral delivery of distigmine bromide. The 
obtained microspheres were characterized by Fourier transform infrared spectroscopy, differential scanning calorimetry, X-ray diffraction and 
scanning electron microscopy. Drug release kinetics of the microspheres is investigated in simulated intestinal fluid pH 7.4 at 37oC. Results 
illustrated that microspheres was influenced by the pH of test mediums, which might be suitable for intestinal drug delivery.  The drug release 
kinetics was analyzed by evaluating the release data using different kinetic models.  
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1. INTRODUCTION 
Polymers (both natural and synthetic) have played a vital 
role in the progression of drug delivery systems through 
microspheres, hydrogels and nanospheres by controlling the 
rate of drug release (both hydrophilic and hydrophobic 
drugs).1 Interpenetrating polymer network (IPN) based on 
the natural polymers is an ingenious drug delivery system, 
with several advantages like high swelling capacity and 
tremendous mechanical strength which plays a significant 
function in the targeted and controlled drug delivery.2, 3 IPN 
has emerged as a trending scaffold to carry the drug within 
its minuscule spherical body and target into specific part of 
the body. Natural polymers or their modified matrix systems 
have several advantages like hydrophilicity, biocompatibility, 
biodegradability and lack of toxicity.4-6 They have 
demonstrated excellent performance in controlled delivery 
of active molecules. 
The karaya gum (KG) is the dried exudates extracted from 
deep incisions in the heartwood of the plant Sterculia urens, 
belonging to family Sterculiaceae.7 Karaya gum is a branched 
polysaccharide, which consists of d-galacturonic acid, d-
galactose, l-rhamnose and d-glucuronic acid. It is a 
glycanorhamnogalacturonan, with alternating backbone units of α-D-galactouronic acid linked at C4 to α-L-rhamnose 
at the C2 position. Substitution occurs on the hydroxyl 
groups by D-galactose and Dglucuronic acid.8 In earlier 
literature, microspheres of KG were used as drug carrier due 
to its biocompatible, biodegradable and good swelling 
properties, it is used for the rate controlling of the drug 
release from the polymer bend matrix.9 
Gelatin (GE) is a proteinous material prepared by the 
thermal denaturation of collagen isolated from fish skins, 
animal skin and bones with very dilute acid.10 Structurally 
gelatin contains many glycine residues, proline and 4-
hydroxyproline residues. Previously M. Aminabhavi et al.11,12 
reported that gelatin can be used as good drug delivery 
vehicle due to its properties like non-toxic, non-irritant, 
biocompatible, biodegradable and edible polymer. Due to its 
wide range properties, it is used in various food and 
pharmaceutical industries.13, 14 In spite of wide range 
properties of GE, GE have major drawback that is quick 
solubilisation in aqueous environments, thus it results faster 
drug release profiles.15 To overcome this drawback GE 
microspheres were chemically crosslinked with 
glutaraldehyde.16 
Distigmine bromide (DSB) (Fig. 1) is a carbamate group 
cholinesterase (ChE) inhibitor; its pharmacological effects 
are characteristically reversible and long lasting.17 It has 
Sreekanth Reddy et al                                                                                           Journal of Drug Delivery & Therapeutics. 2019; 9(3-s):1-11 
ISSN: 2250-1177                                                                                  [2]                                                                                 CODEN (USA): JDDTAO 
been used in the treatment of Detrusor underactivity. 
Detrusor underactivity is a failure to achieve complete 
bladder emptying within a normal time span. Distigmine 
inhibits cholinesterase and thus increases the action of 
acetylcholine. Depending on its dosage, distigmine affects the 
central nervous functions other than urinary bladder.18, 19 
Commercially available polymers have few limitations like 
low encapsulation efficiency, burst release of drug and quick 
solubilisation.20 To overcome these limitations pH-sensitive 
polymer of KG is used in delivery system because it acts good 
drug release controlling agent21 in the matrix and also it 
shows better mucoadhesion compared to other gums.22 In 
the present work, GE is blended with KG to form controlled 
release matrix and chemically cross linked with 
glutaraldehyde to form cross linked microspheres (Scheme. 
1). The main objective of the present work is to deliver drug 
loaded microspheres orally in sustained and controlled 
manner.
 
 
Fig. 1. Structure of Distigmine Bromide 
 
Scheme 1. Possible Schematic representation for the formation of polymer blend microspheres 
 
2. EXPERIMENTAL 
2.1. Materials 
Gelatin and Karaya gum are purchased from Sigma–Aldrich 
(USA). Light liquid paraffin, Glutaraldehyde and tween-80 
were purchased from Sd.Fine chemicals, Mumbai, India. 
Glycine and n-hexane were purchased from M/S moly 
chemicals, Mumbai (India). Water used was of high purity 
grade after double distillation. 
2.2. Preparation Procedure 
Drug loaded blend microspheres of GE and KG were 
prepared by the water-in-oil (w/o) emulsion cross-linking 
method.23 Briefly, 10% of GE and KG aqueous dispersions of 
each were prepared separately using distilled water. Various 
formulations of GE/KG blend matrix (as per the given in 
table.1) were prepared by mixing with magnetic stirrer 
(Remi Motors, India) at 400 rpm for 4hrs. To the above 
polymer blend matrix different quantities of drug were 
added and stirred with magnetic stirrer to obtain 
homogeneous solution. The resulting blend solution was 
emulsified by adding drop wise into 100 mL of paraffin 
liquid light containing 1% tween-80 through a glass syringe. 
The emulsion was stirred at speed of 500 rpm for 20min. 
After 20min, crosslinker GA was added to cross link the 
blend matrix and stirred at 500 rpm for another 2hr. The obtained microspheres were then ﬁltered and washed with 
n-hexane to remove paraﬃn liquid light. Microspheres were 
again washed with 0.1 M glycine solution and deionised 
water simultaneously to remove the unreacted GA. Finally 
the microspheres were dried in air overnight and then 
vacuum-dried to constant weight at 40oC. 
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Table 1: Formulation, Composition, Yield and Encapsulation Efficiency (%EE) of all samples 
S.No Formulation 
GE 
(W/w %) 
KG 
(W/w %) 
Drug 
(mg) 
GA 
(mL) 
%EE 
Wt. of 
microspheres 
% 
yield 
1 GK1 90 10 60 1 47.90 0.974 48.7 
2 GK2 80 20 60 1 50.15 1.225 61.2 
3 GK3 70 30 60 1 56.15 1.128 56.4 
4 GK4 80 20 50 1 48.62 1.108 55.4 
5 GK5 80 20 100 1 54.54 1.327 66.3 
6 GK6 80 20 150 1 60.20 1.361 68.0 
7 GK7 80 20 80 1 52.60 1.214 60.7 
8 GK8 80 20 80 2 48.40 1.217 60.8 
9 GK9 80 20 80 3 44.17 1.112 55.6 
10 GK10 80 20 00 2 00.00 1.271 63.5 
 
2.3. Characterizations Methods 
2.3.1. Fourier Transform Infrared (FTIR) Spectral 
Analysis 
Fourier-Transmission IR (FT-IR) spectra of GE, KG, pure 
drug, placebo microspheres and drug loaded microspheres 
were measured as pellets in KBr with a FT-IR 
spectrophotometer (model Bomem MB-3000, with Horizon 
MBTM FTIR software) in the wavelength range of 400–4000 
cm-1 to find out the possible chemical interactions between 
polymers and drug. 
2.3.2. Differential Scanning Calorimetry (DSC) 
DSC analysis of plain drug, placebo microspheres, and drug 
loaded microspheres were carried out using 
Thermogravimetry analyzer Rheometric Scientific, Model 
DSC-SP, UK. About 5-7 mg of sample was placed into alumina 
crucible and the thermo grams were recorded between 30 oC 
to 300 oC at a heating rate of 10 oC/min under nitrogen 
atmosphere.   
2.3.3. X-Ray Diffraction (XRD) Analysis 
The X-ray diffraction of pristine drug, placebo microspheres 
and drug loaded microspheres were performed by a wide 
angle X-ray scattering diffractometer (Panalytical X-ray 
Diffractometer, model-Xǯpert ProȌ with CuKα radiation ȋɉ= 
1.54060) at a scanning rate of 10°/min to determine the 
crystallinity. 
2.3.4. Scanning electron microscopy (SEM) Analysis 
The morphological characterization of microspheres was 
observed by using SEM (JOEL MODEL JSM 840A) with an 
accelerated voltage of 20 kV equipped with an EDAX 
detector. 
2.3.5. UV-VIS spectrum analysis of distigmine bromide 
10 mg of DSB dissolved in 10 mL of methanol, and this was 
transferred into a 100 mL standard flask. The volume was 
brought up to the mark with methanol to obtain a stock solution of DSB with ͳͲͲ Ɋg/ml final concentration. ʹ ml 
sample was transferred into a 10 ml standard flask and the 
volume was made up to the mark with methanol to prepare a concentration of ʹͲ Ɋg/ml. The sample was further scanned 
by a UV-VIS Spectrophotometer (LabIndia, Mumbai, India) in 
the range of 200 – 400 nm, using methanol as a blank.24, 25 
2.4. In vitro drug release 
2.4.1. Determination of encapsulation efficiency 
Percentage of encapsulation efficiency are estimated 
according to the formula and method reported in previous 
literature.26 A known mass of drug loaded microspheres 
(10mg) were immersed into 100mL of phosphate buffer 
solution (pH 7.4 containing 5% absolute ethyl alcohol) for 24 
hr and then vigorously stirred the microspheres to ensure 
the complete extraction of distigmine bromide from the 
microspheres. The solution was then filtered and analyzed 
by ultraviolet (UV) spectrophotometer (LabIndia, Mumbai, )ndiaȌ at the ɉ-max of 271.60 nm with pH 7.4 buffer solution 
as a blank. Concentration of drug was determined by using 
calibration curve constructed by series of DSB standard 
solutions. Percentage of encapsulation efficiency was 
calculated by the following equation. 
Encapsulation efficiency (%) = 
            (eq.1) 
Where Wt is the total amount of drug in the microspheres 
and Wi is the total quantity of drug added initially during the 
preparation. 
2.4.2. In vitro drug release studies 
To study the in vitro drug release studies of different 
formulations were performed at 37 oC using a dissolution 
tester (Lab India, Mumbai, India) capable of eight baskets. 
Accurate quantity of microspheres (100mg) was immersed 
into 900mL of phosphate buffer solution pH7.4 at a rotation 
speed of 50 rpm to replicate intestinal atmosphere. At 
regular intervals of time, aliquot samples were withdrawn, and analyzed using UV spectrophotometer at fixed ɉ-max 
value of 271.60 nm, and the released drug amount was 
obtained by using concentration versus absorbance 
calibration curve. 
2.5. Drug release kinetics 
The drug release kinetics was analyzed by fitting the data in 
to kinetic models, which include zeroth, first order, higuchi 
and Korsmeyer-peppas. Based on the goodness of data fit, 
the most suitable model was also determined.27 
2.5.1. Zeroth-Order 
Zero order (eq.2) describes the system where the drug 
release rate is independent of its concentration. To study the 
drug release kinetics, data obtained from in vitro drug 
release studies were plotted as cumulative amount of drug 
release versus time, will be linear.28, 29   
C= C0-K0 t     (eq.2) 
where C is the amount of drug dissolved in time t, C0 is the 
initial amount of drug in the solution (most times, C0 = 0) and 
K0 is zeroth-order rate constant, expressed in units of 
concentration/time. 
This model is used to determine the drug dissolution release 
of matrix tablets with low soluble drugs and in some 
transdermal systems. 
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2.5.2. First order 
First order rate kinetics (eq.3) describes release rates that 
are concentration dependent. The drug release which follows 
the first order kinetic can be expressed by the equation -2.30                (eq.3) 
Where K is first order rate constant expressed in units of 
time-1. Rearranging the equation (2) and taking logs on both 
sides expressed as: 
log C = log C0 - Kt / 2.303         (eq.4) 
where C0 is the initial concentration of drug, k is the first 
order rate constant, and t is the time. To study the first order 
kinetics, data obtained are plotted as log cumulative 
percentage of drug remaining vs. time will be linear, with 
negative slope of -K/2.303. This model is used to determine 
drug dissolution of water soluble drugs in porous matrices.  
2.5.3. Higuchi model 
Higuchi proposed a mathematical equation31, 32 to describe 
drug release from matrix system. Initially it was applied for 
planar systems with homogenous matrix, later it was 
extended to different geometrics and porous systems. The 
amount of drug per unit area for homogeneous matrix is 
given by eq.5. 
ft = Q = A √DȋʹC - Cs) Cs t          (eq.5) 
Where Q is the amount of drug released in time t per unit 
area A, C is the drug initial concentration, Cs is the drug 
solubility in the matrix media and D is the diffusivity of the 
drug molecules in the matrix substance. 
The above equation (4) is simplify to eq.6 (generally known 
as simplified higuchi equation)  
ƒt = Q= KH t1/2      (eq.6) 
The data obtained were plotted as cumulative percentage 
drug release versus square root of time, exhibits linear 
relationship. Higuchi describes drug release as a diffusion 
process based on the Fick's first law. Higuchi model 
describes the drug dissolution in pharmaceutical dosage 
forms like some transdermal system and matrix tablets with 
water soluble drugs. 
 
2.5.4 Korsmeyer-peppas model  
Drug release kinetics is analyzed by plotting the cumulative 
release data versus time by fitting to the following empirical 
equation33: 
 
     = ktn         (eq.7) where Mt and Mα are the cumulative amount of distigmine 
released at time t and equilibrium time, respectively, k is a 
kinetic constant, and n is the diffusional exponent which 
suggests the nature of the release mechanism. The n values are determined from the slope of the plot of lnȋMt/MαȌ 
versus lnt. A value of n = 0.5 indicates the Fickian diffusion 
(case I transport), while polymer chain relaxation becomes 
the rate-controlling factor for case II transport (relaxation 
controlled) if n = 1.0. When the value of n is between 0.5 and 
1.0, the release follows anomalous or non-Fickian diffusion, 
where the system will be diffusion and relaxation controlled. 
3. RESULTS AND DISCUSSION 
3.1. FTIR Spectral Analysis 
FTIR spectra of GE (a), KG (b) and blend microspheres (c) 
are displayed in Fig. 2. FTIR spectra of GE (Fig. 2.a) a broad 
band at 3341 cm-1 corresponded to stretching vibration of N – H group, whereas amide (C = O) stretching vibrations are 
observed at 1629 cm-1. Furthermore, absorption band at 
1382cm-1 assigned to stretching vibrations of C – N bond. 
The bands observed at 2923 and 2854 cm-1 represents 
aliphatic C-H asymmetric and symmetric stretching 
vibrations respectively. FTIR spectra of KG (Fig. 2.b) shows a 
characteristic peaks at 3395 cm-1 corresponds to O-H 
stretching frequency, the peaks arises at 1729 cm-1 assigned 
to carbonyl group of carboxylic acid. Furthermore the 
absorption band at 1041 corresponds to C-O stretching 
frequency of alcoholic group. A similar observation was 
reported by V.V. Alange et al.,8 from the functionally modified 
polyacrylamide-graft-gum karaya pH-sensitive spray dried 
microspheres for colon targeting of an anti-cancer drug. FTIR 
spectra of placebo microspheres (Fig. 2.c) a new band 
formed at 1627 cm-1 is assigned to C=N stretching vibrations 
which indicates the interaction between carboxylic group of 
KG and GE group of NH2 which confirms the formation of 
microspheres. The band at 1459 cm-1 further confirms the 
cross-linking of the amino group of GE with the aldehyde 
group of GA.34 
 
 
Fig. 2. FTIR spectra of GE (a), KG (b) and Placebo microspheres (c) 
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FTIR spectra of pure drug (a), placebo microspheres (b) and 
drug loaded microspheres (c) were displayed in Fig. 3. For 
pure drug (Fig. 3.a) a band observed at 1735 cm-1 represents 
amide (C = O) stretching vibrations. Comparing the FTIR 
spectra of placebo microspheres and drug loaded 
microspheres, in placebo microspheres (Fig. 3.b) a band 
appears at 1627 cm-1, whereas this band was shifted to 
lower wavelength i.e. 1620 cm-1 in drug loaded 
microspheres (Fig. 3.c) which indicates the interaction 
occurs between polymer and drug, the C=O stretching 
frequency decreased due to the formation hydrogen bonding 
interaction between drug molecule and polymer chains (-
NH2 group and –C=O group of drug molecule). The band at 
1548 cm-1 further indicates the formation of N-H bending 
vibration of amide group, which confirms the interaction 
between drug (-NH2) and polymer matrix (-C=O).  
 
 
 
Fig. 3. FTIR spectra of drug (a), placebo microspheres (b) and drug loaded microspheres (c) 
 
3.2. DSC Analysis 
DSC thermograms of pristine distigmine bromide (a), 
placebo microspheres (b) and drug loaded microspheres (c) 
are shown in Fig.4. The pure distigmine bromide (Fig. 4.a) 
shows a sharp peaks at 162.25 oC, which corresponds to its 
polymorphism and melting point respectively. However 
these peaks are not observed in drug loaded microparticles 
(Fig. 4.c) which confirms the amorphous dispersion of drug 
molecules in the polymer matrix. 
 
 
Fig. 4. DSC thermograms of pure distigmine bromide (a), placebo microspheres (b) and drug loaded microspheres (c). 
Sreekanth Reddy et al                                                                                           Journal of Drug Delivery & Therapeutics. 2019; 9(3-s):1-11 
ISSN: 2250-1177                                                                                  [6]                                                                                 CODEN (USA): JDDTAO 
3.3. XRD Analysis 
Powder XRD patterns of pristine distigmine bromide (a), 
distigmine loaded microspheres (b) and placebo 
microspheres (c) were displayed in Fig. 5. The XRD pattern 
of pristine distigmine bromide (Fig. 5.a) shows a 
characteristic peaks at 2θ of 16.51o, 22.02o, 23.76o, and 
27.08o, represents the crystalline nature. Whereas the 
crystalline peaks are not completely observed in distigmine 
bromide loaded microsphere (fig. 5.c), this suggests that the 
drug is dispersed at molecular level in the polymer matrix.
 
 
Fig. 5. Powder XRD patterns of pristine distigmine bromide (a), distigmine bromide loaded microspheres (b) and placebo 
microspheres (c) 
3.4. SEM and EDS Analysis 
To understand the morphology and chemical composition of 
microspheres, SEM and EDS analysis were performed and 
the images are represented in Fig. 6. From Fig. 6, it was 
observed that the microspheres are spherical in shape 
having rough surface. The rough is ascribed to the use of 
glutaraldehyde as a crosslinker.35 On comparing the placebo 
microspheres (Fig. 6.c) shows smooth surface, whereas the 
drug loaded microspheres (Fig. 6.d) shows rough surface 
having pores on theirs surface, this indicates drug should be 
loaded in the microspheres. These pores enhance the 
diffusion of the drugs. From the SEM studies the average size 
of the microsphere was found to be 20-4ͲɊm. 
The chemical compositions of the placebo microspheres and drug loaded microspheres were conﬁrmed by energy-
dispersive X-ray spectra (EDS) and the images were 
displayed Fig. 6.e & 6.f. The dominant oxygen peak in EDS of 
different microspheres indicates the presence of hydroxyl 
groups of the polymer molecules. On comparing the EDS 
spectra of placebo microspheres (Fig. 6.e) and drug loaded 
microspheres (Fig. 6.f), in both spectra nitrogen peaks were 
observed indicating the presence of gelatin polymer. But the 
nitrogen peak in drug loaded microspheres was more 
intense than the peak present in placebo microspheres, 
because the drug consists of nitrogen element which gives 
more intense peak in drug loaded microspheres. The results 
suggesting that the drug was loaded in microspheres. 
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Fig. 6. SEM analysis of Placebo microspheres (A, C), drug loaded microspheres (B, D) and EDS analysis of Placebo microspheres 
(GK10) & drug loaded microspheres (GK6). 
3.5. UV-VIS spectrum analysis of distigmine bromide. 
The sample was scanned by a UV-VIS Spectrophotometer in 
the range of 200 – 400 nm, using methanol as a blank. The 
wavelength corresponding to the maximum absorbance ȋɉmax) was found to be 271.60 nm. This was further utilized 
to obtain a calibration curve. 
3.6. Encapsulation efficiency 
The percentages of encapsulation efficiency (%EE) of 
distigmine bromide loaded microspheres are listed in 
Table.1, lies in between 44.17 % to 60.20 %. This indicates 
the %EE dependence on formulation parameters which 
include % of blend composition, extent of drug loading and 
concentration of cross-linker. With increase the percentage 
of GE in blend composition, the %EE decreased, because GE 
might have assisted the diffusion of drug particles into the 
external surface, to form pores in the matrix. This effect was 
observed in formulations of GK1, GK2 and GK3. Percentage of 
drug loading increases %EE also increases. This effect can be 
observed in GK4, GK5 and GK6. As the concentration of 
cross-linker increases, %EE decreased because the cross-
linking density increases in the matrix, which reduced the 
free volume spaces in the matrix, this effect was observed in 
the formulations of GK6, GK7 and GK8. A similar observation 
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was reported by Madhusudana Rao et al.,36 through the IPN 
microspheres for in vitro release studies of an anti-cancer 
drug. 
3.7. In Vitro Drug Release Studies  
In vitro drug release studies are discussed in terms of 
polymer blend composition, % of drug loading and 
crosslinker variation. 
3.7.1. Effect of GE/KG blend composition 
To investigate the effect of Polymer blend composition on in vitro release proﬁles was studied by plot the cumulative % of 
drug release data against time. The drug release profiles of 
GK1, GK2 and GK3 are 85.1%, 80.3% and 76.2% respectively 
are displayed in Fig. 7. This suggests that drug release rate 
decreases with increasing content of KG, due to its better 
drug retarding capability37 and also due to the presence of 
ester linkages and methyl groups in karaya gum which 
increases the hydrophobicity of the matrix, thereby 
decreasing the release rates of drug, a similar observation 
was reported by chowdoji rao et. al.,38 by the formulation 
prepared karayagum and sodium alginate for control release 
of flutamide drug delivery studies. This indicates the KG 
content increases in the blend matrix, percentage of drug 
release rate decreases. 
 
 
 
Fig. 7. Effect of polymer blend composition on % of DSB release in pH7.4 at 37oC 
 
3.7.2. Effect of Drug loading 
Fig. 8. Shows the effect of drug variation on in vitro release proﬁles was studied at a constant amount of polymer blend 
composition and crosslinker.  The amount of drug loaded for 
GK4, GK5 and GK6 are 50, 100 and 150mg respectively. The 
cumulative percentage drug release for GK4, GK5 and GK6 
are 77.7%, 83.1% and 86.5% respectively. The drug release 
rate of GK6 is higher. It was clear that the drug content is 
high the drug release rate is increases. This indicates that 
release rates vary depending on the amount of drug in the 
matrices, i.e., the release rate was found to be significantly 
faster at higher amounts of drug and slower at lower 
amounts of DSB in the matrix; this might be due to the 
availability of extra free void spaces through which fewer 
drug molecules will transport. 
 
 
Fig. 8. Effect of Drug loading on % of DSB release in pH7.4 and 37oC 
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3.7.3. Effect of crosslinker variation 
To study the effect of crosslinker variation on in vitro release proﬁles was studied at a constant amount of polymer blend 
composition (80% w/w GE and 20% w/w KG) and drug 
(80mg). We have chosen the formulations GK6, GK7 and GK8 
(prepared with 3mL, 2mL and 1mL of GA respectively) and 
their drug release profiles are displayed in Fig. 9. The 
cumulative percentage of drug release for GK6, GK7 and GK8 
are 81.9%, 77.6% and 74.2% respectively. The cumulative 
percentage of drug release rate of GK6 is higher crosslinked 
with 1mL of GA where as GK8 shows lower release rate 
which is crosslinked with 3mL of GA. It was clear that the 
crosslinker amount increases, the cumulative % of drug 
release rate decreases because crosslinker decreases the 
size of the pores presents on the blend microspheres, 
thereby hindering easy transport of drug molecules through 
the matrix.39 
 
 
Fig. 9. Effect of crosslinker on % of DSB release in pH7.4 at 37oC 
 
3.7.4. Drug release kinetic models 
The drug release kinetics of distigmine bromide of all 
profiles was determined based on the best fit of kinetic 
models tested, which include: zeroth-order, first order and 
higuchi model. The r2 values for zeroth-order, first order and 
higuchi model are 0.9409, 0.9699 and 0.9908 respectively 
(Fig.14). The best fit to current data is higuchi model. 
According to Higuchi model, during the time of drug release 
from the polymer matrix, surrounding liquid penetrates in to 
the matrix, and dissolves the drug, which then leaching out 
of the drug through interstitial channels or pores.40 In the 
case of hydrophilic matrices, swelling and matrix dissolution 
of the polymer occurs simultaneously, and both of them 
contribute to the overall drug-release rate.41 Based on the 
results of Higuchi and Korsmeyer-Peppas data, it was clear 
that the drug release profile follows simple diffusion 
process. This was further revealed by Korsmeyer-Peppas 
model. The first 60% drug release data were fitted into 
Korsmeyer- Peppas model.42      = ktn Where, Mt/Mα represents the fractional drug release at time 
t, k is a constant characteristic of the drug-polymer system 
and n is the release exponent indicating the type of drug 
release mechanism. In the present study the values n are 
obtained in the range of 0.421-0.586 indicates Fickian 
diffusion mechanism. These results, along with correlation coefficients Ǯr2ǯare presented in Table ʹ. 
 
Table 2: Drug release rate constant and correlation coefficient of all formulations after fitting drug release data into different 
mathematical models 
S.No Sample Zero order First order Higuchi Korsmeyer-Peppas 
  k0 r2 k1 r2 KH r2 n r2 
1 GK1 15.38 0.941 1.937 0.978 23.40 0.982 0.475 0.983 
2 GK2 16.64 0.951 1.935 0.947 16.00 0.981 0.421 0.986 
3 GK3 11.99 0.948 1.947 0.972 14.98 0.990 0.428 0.991 
4 GK4 12.45 0.946 1.949 0.971 21.12 0.979 0.486 0.979 
5 GK5 15.09 0.900 1.940 0.950 28.98 0.989 0.545 0.988 
6 GK6 17.84 0.904 1.935 0.972 33.24 0.994 0.573 0.995 
7 GK7 13.62 0.949 1.945 0.975 22.28 0.968 0.461 0.956 
8 GK8 11.11 0.957 1.957 0.983 22.21 0.973 0.461 0.952 
9 GK9 08.75 0.959 1.969 0.984 23.02 0.964 0.586 0.956 
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CONCLUSION 
In this study, semi IPN microspheres were fabricated from 
GE and KG by simple water-in-oil (w/o) emulsion cross-
linking method using GA as a crosslinker. Microbeads 
formation was confirmed by FTIR spectroscopy. DSC & X-RD 
confirms the molecular level dispersion of drug. SEM studies 
reveal that the beads were spherical in shape with smooth 
surface. The in vitro release study indicates the distigmine 
bromide released in a controlled manner. The in vitro 
release kinetics was assessed by different empirical 
equations and the data supported a Fickian diffusion 
mechanism. The results suggested that the semi IPN 
microspheres will be good carriers for emerging drug 
delivery systems. 
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